NCCN 2^nd Annual Congress: Hematologic Malignancies – Transfusion Support and Iron Overload in Myelodysplastic Syndromes

Download Podcast

Listen to MP3

Podcast Evaluation

A presentation from the NCCN 2^nd Annual Congress: Hematologic Malignancies™ held September 14-15, 2007, in New York, New York

Presenter

Stephen D. Nimer, MD
Memorial Sloan-Kettering Cancer Center
New York, New York

Program Overview

Some patients with myelodysplastic syndromes experience anemia and receive blood transfusions as supportive therapy.  While such therapy can be helpful in treating anemia, a patient may end up with elevated levels of iron after repeated transfusions.  This presentation will focus on the causes, complications, monitoring, and treatment of iron overload.  Risk assessment, prognostic scoring systems, and currently available iron chelators will be highlighted.

Educational Objectives

Following this activity, participants should be able to:

• Describe the clinically relevant subtypes of myelodysplastic syndromes and risk assessment with respect to their roles in selecting therapy
• Define best practices for the management of iron overload

Intended Audience

This educational activity is designed to meet the needs of physicians, nurses, and other clinical professionals who manage patients with cancer.

Activity Instructions

Continuing education credit will be awarded to participants who view the presentation, pass the post-test with a score of 80% or higher, and complete the evaluation.  Participants should review the learning objectives and faculty disclosure statement prior to viewing and listening to a presentation in its entirety.  You must be connected to the Internet in order to review and complete the post-test and the evaluation form.  A statement of credit will be electronically generated once you pass the post-test and complete the evaluation form.  To receive credit, this activity must be completed no later than November 1, 2008.  There is no fee for participating in this activity.

Download Podcast

Listen to MP3

Podcast Evaluation

Accreditation Information

Physicians

The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.

NCCN designates this educational activity for a maximum of 0.5 AMA PRA Category 1
Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses

This activity is approved for 0.6 contact hours.  National Comprehensive Cancer Network is an approved provider of continuing nursing education by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product.

Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity.

Release date:  November 1, 2007
Expiration date:  November 1, 2008

Commercial Support

Distribution supported by an educational grant from Novartis Oncology